Route scouting and process development

Our state-of-the-art laboratories are fully equipped for fast and efficient route evaluation, selection and scale-up for all types of chemistry, including highly potent compounds, antibiotics, hormones and controlled substances. Everything we do is designed to get you to your IND filing faster and cleaner. There is no minimum program size. Your program receives senior scientific attention from day one.

Selecting the right synthesis route is key to ensuring successful development and scale-up across clinical phases and meeting your API program requirements. Our highly experienced scientists focus on robustness, effectiveness, purity, scalability and safety of complex, multi-step chemical processes, ensuring the identified route can support your program from preclinical development through to commercial supply.

API process development refers to the design of a synthetic route and the development and manufacture of small molecule drug substances. The goal is to create a robust, safe and scalable process that enables control of API quality. We also understand that every dollar matters and focus on economically viable routes. It typically involves multiple stages, including route scouting, process development, scale-up, impurity characterisation and solid-form studies.

We support clients from lead through to preclinical and early clinical phases. By embedding process thinking, solid-state science and regulatory intelligence from the earliest stages, Nuvisan helps you reach your IND submission—and your CDMO handover—prepared, not surprised.

Our laboratories support a broad range of chemistries. This infrastructure enables fast and efficient route evaluation, selection and scale-up, regardless of the complexity of your target compound.